Best Peptides for Sleep: What the Community Actually Uses (2026)
The peptides most used for sleep split into two camps — the growth-hormone (GH) axis stack Ipamorelin + CJC-1295 leads, followed closely by the sleep-specific peptide DSIP, then oral MK-677 — but "most used" is not the same as "best for you," and none of them is FDA-approved as a sleep aid. This page answers the real question two ways at once: what the ProtocolPlus community reaches for to sleep better, and what the evidence actually says about each option.
Most "best peptides for sleep" lists rank compounds by an author's opinion, and most blur a crucial distinction: peptides that make you feel sedated versus peptides that change your sleep architecture (deep and REM sleep). We separate them, and we match the right tool to the right problem. The headline ranking below comes from first-party usage data — what ~2,600 ProtocolPlus users pursuing better sleep actually track — and we keep the editorial "why" clearly separate as context, never as the ranking. For how to measure your own sleep changes, and when to dose for deep sleep, we link sideways to the pages that own those questions.
Key Takeaways
- What the community uses (not an efficacy ranking): across ~2,600 ProtocolPlus users pursuing better sleep, the top three are Ipamorelin + CJC-1295 (26%), DSIP (24%), and MK-677 (16%) — together about two in three (ProtocolPlus app data).
- What the community uses ≠ what is proven best. Usage reflects availability, cost, biohacker hype, and forum momentum as much as evidence. Read the ranking as a popularity signal, then weigh it against the evidence tiers below.
- None is FDA-approved as a sleep aid. Sermorelin is the only FDA-approved molecule here, but for adult GH-deficiency diagnosis, not sleep. Everything else is investigational or research-only, and DSIP's evidence is largely older preclinical/Russian work.
- Match the peptide to your sleep problem. Trouble falling asleep (latency), waking through the night (fragmentation), a racing anxious mind at lights-out, or age-related decline in deep sleep each point toward a different first pick. Use the triage matrix below.
- "Feels like sedation" vs "improves architecture." Most of these do not knock you out like a sleeping pill; the GH-axis stack and DSIP aim to deepen slow-wave sleep, which is a quieter, slower change you often only see on a tracker.
- What the data does NOT show: no peptide here treats sleep apnea, restless legs, or any diagnosed sleep disorder, and there are no large randomized sleep trials for any of them. Fix sleep hygiene first; a peptide is never the foundation.
What peptides does the ProtocolPlus community use for sleep?
Across ~2,600 ProtocolPlus users pursuing better sleep, the Ipamorelin + CJC-1295 GH-axis stack is the most-tracked option (26%), followed closely by the sleep-specific peptide DSIP (24%) and oral MK-677 (16%) — together about two in three users. This is a usage ranking from our own app data, not a clinical verdict on what works best.
The pattern tells a two-camp story. One camp chases deeper sleep through the growth-hormone axis, because your biggest GH pulse fires in early deep sleep, so Ipamorelin + CJC-1295 leads and MK-677 rides along as the oral version. The other camp goes straight at sleep itself, which is why DSIP — a peptide literally named "delta sleep-inducing peptide" — sits almost level at the top. After the leaders, usage drops into a tail: selank (12%), the anxiety-onset pick that also shows up on our best peptides for focus and cognition list for daytime calm-focus; sermorelin (10%), the milder GHRH; epitalon (8%), the circadian/melatonin-rhythm outlier; and a small remainder (4%).
These shares come only from our community-usage dataset and describe behavior, not efficacy. A compound can be widely used and thinly evidenced at the same time, and most sleep peptides sit exactly there, with small, old, or preclinical data rather than large human sleep trials. Read this chart as "what people in the community reach for," then cross-check it against the evidence tiers in the triage matrix further down.
Citation capsule. Among ~2,600 ProtocolPlus users who logged better sleep as a goal, the most-tracked compounds were Ipamorelin + CJC-1295 (26%, 676 users), DSIP (24%, 624), and MK-677 (16%, 416). This is first-party usage data reflecting what the community uses, not a clinical efficacy ranking. Source: ProtocolPlus app data (goals/sleep.json), 2026.
The community's top 3 picks (by usage)
The community's three most-used sleep peptides are Ipamorelin + CJC-1295, DSIP, and MK-677 — two GH-axis approaches that deepen sleep and one peptide aimed at sleep directly. Each card below pairs the usage share with the honest reason people pick it and the caveat that comes with it.
These three account for roughly 66% of sleep usage in our cohort. The split tracks the two-camp logic: most people chasing better sleep are really chasing deeper, more restorative sleep, and they reach either for the GH axis (which deepens slow-wave sleep as a side effect) or for a peptide built for sleep itself. The injectable GH stack leads, the sleep-specific peptide sits right beside it, and the oral GH option rounds out the top three.
Ipamorelin + CJC-1295
Why people pick it: the community's default GH-axis stack — a clean GH-releasing peptide plus a GHRH analog, aimed at a stronger overnight GH pulse and deeper slow-wave sleep, with better next-day freshness.
Honest caveat: no controlled human sleep trial on the combination; it deepens sleep, it does not sedate; research-grade vials are unregulated; raises IGF-1, which needs monitoring.
DSIP
Why people pick it: the one peptide built for sleep — "delta sleep-inducing peptide," used to target sleep quality and latency directly rather than through the GH axis.
Honest caveat: its human evidence is old, small, and largely Russian/preclinical; results are mixed; it is the most-hyped and least-cleanly-evidenced of the leaders.
MK-677 (Ibutamoren)
Why people pick it: the oral, needle-free way to nudge the same GH axis; valued for deeper sleep and appetite, with the most human pharmacology data of the GH-secretagogue group.
Honest caveat: water retention, vivid dreams, and morning grogginess are common; raises IGF-1; not a peptide (it is an oral secretagogue) and not approved.
The long tail (ranks 4–7): the remaining ~34% of usage spreads across selank (12%), sermorelin (10%), epitalon (8%), and a small mix including tesamorelin and BPC-157 (4%). Selank is the anxiolytic pick for an anxious, racing mind at lights-out; sermorelin is the milder, FDA-approved-for-diagnosis GHRH; epitalon is the circadian/melatonin-rhythm outlier people try for age-related decline; the remainder is off-the-core for sleep. Each gets a mini-section below.
How do peptides for sleep actually work?
Sleep peptides work two different ways: GH-axis compounds (Ipamorelin + CJC-1295, MK-677, sermorelin) deepen slow-wave sleep as a side effect of raising your overnight growth-hormone pulse, while sleep-direct peptides (DSIP, selank) act on sleep and calming pathways themselves. Knowing which mechanism you are reaching for is the difference between fixing the right problem and chasing the wrong one.
This split is why the usage ranking has two leaders instead of one. Your largest GH pulse normally fires in the first few hours of sleep, locked to slow-wave sleep (Endocrine Reviews / NIH, Van Cauter et al., 1998, retrieved 2026-06-19). GHRH analogs like CJC-1295 and sermorelin tell the pituitary to release more GH; GH-releasing peptides and secretagogues like ipamorelin and MK-677 do it through a second receptor; together they aim to raise that nightly pulse and the deep sleep that rides with it. That is why people describe these as "deeper sleep, not knocked out." We keep the receptor-by-receptor detail on each compound's hub; for how to read your own deep-sleep numbers, see how to track sleep changes on peptides.
The sleep-direct peptides sit outside the GH story. DSIP is a small peptide historically described as promoting delta (slow-wave) sleep and easing sleep onset, though the human work behind that reputation is old and limited. Selank is an anxiolytic peptide that helps sleep indirectly by lowering pre-sleep anxiety rather than sedating you. Epitalon is different again, a pineal-pathway peptide tied to melatonin and circadian rhythm rather than to a single night's sleep. The honest version: the GH-axis mechanism is well described in physiology, but whether nudging any of these with research-grade peptides produces a meaningful, lasting sleep benefit in healthy people is not established in large controlled trials. For the foundations of how injectable peptides act in the body, see how peptides work.
Citation capsule. Sleep peptides act through two routes: GH-axis secretagogues (ipamorelin, CJC-1295, MK-677, sermorelin) deepen slow-wave sleep by amplifying the natural overnight GH pulse, which fires in early sleep; sleep-direct peptides (DSIP, selank) target sleep onset and pre-sleep anxiety. The GH pulse–deep sleep link is well described; large human sleep trials for these peptides do not exist. Source: Endocrine Reviews / NIH (Van Cauter, 1998); compound mechanisms per each hub.
Which sleep problem are you actually solving?
The single most useful move on this page is matching the peptide to your specific sleep problem: trouble falling asleep, waking through the night, an anxious racing mind at lights-out, or age-related decline in deep sleep each point to a different first pick. The triage matrix below is the page's signature: pick your row, read across.
This is the differentiator the opinion-listicles miss. "Best peptide for sleep" is the wrong question; "best peptide for my sleep problem" is the right one. The selector quiz at the top runs this exact logic interactively. If your issue is sleep latency (you lie awake), the calming or sleep-onset picks fit best. If it is fragmentation (you wake at 3 a.m.), the deep-sleep-deepening GH-axis tools fit better. If it is anxiety-onset (a racing mind), selank's anxiolytic angle is the match. If it is age-related decline in deep sleep, the GH-axis stack and the circadian-rhythm outlier epitalon are where the community looks.
| Your sleep problem | What it feels like | Community first pick | Why it fits | Evidence grade (2026) |
|---|---|---|---|---|
| Latency (falling asleep) | You lie awake 30+ minutes at lights-out | DSIP, then Selank | Sleep-onset / calming peptides target the start of the night, not depth | Limited / mixed human (DSIP); small human (Selank) |
| Fragmentation (staying asleep) | You wake through the night or too early | Ipamorelin + CJC-1295, then MK-677 | GH-axis tools deepen slow-wave sleep, the most consolidating phase | Human GH-rise data; no sleep-trial endpoint |
| Anxiety-onset (racing mind) | A busy, wired brain refuses to switch off | Selank | An anxiolytic peptide that lowers pre-sleep anxiety rather than sedating | Small human anxiolytic data; not sleep-specific |
| Age-related decline (thin deep sleep) | Deep sleep shrinks with age; lighter, shorter nights | Ipamorelin + CJC-1295, then Epitalon | GH axis rebuilds slow-wave depth; epitalon targets circadian/melatonin rhythm | GH data (stack); preclinical/old data (epitalon) |
| Disrupted rhythm (shift / jet lag) | Your clock is out of sync, not your sleep quality | (Off-core) Epitalon, melatonin basics | Circadian-rhythm tools, not depth tools; mostly a hygiene/light problem | Preclinical (epitalon); link out |
"Choose X if…" — the quick decision
If you only read one section, read this: each card below names the sleep problem and the community's first pick for it, with the honest catch. Match your problem, then go read that compound's hub before you do anything.
The point is to stop you buying the most-hyped peptide and start you buying the one that fits your actual night. DSIP gets the loudest forum attention, but if your problem is a racing anxious mind, selank is the better-matched tool; if it is thin, fragmented deep sleep, the GH-axis stack is.
DSIP is the community's sleep-onset pick, built to target latency directly. Catch: its human evidence is old and mixed, so treat it as an experiment and track your latency.
Ipamorelin + CJC-1295 deepens slow-wave sleep, the most consolidating phase, so it targets fragmentation. Catch: it deepens, it does not sedate, and it raises IGF-1.
Selank is anxiolytic; it lowers pre-sleep anxiety rather than knocking you out. Catch: it is not a sleep drug, so it helps onset only when anxiety is the real blocker.
Ipamorelin + CJC-1295 first (rebuilds slow-wave depth), with Epitalon as the circadian-rhythm experiment. Catch: epitalon's data is preclinical and old.
What does the evidence actually grade out at?
Honest grade: no sleep peptide here has large controlled human-trial evidence for sleep — the GH-axis leaders rest on physiology and pharmacology data, DSIP rests on old and mixed human work, and the rest are small or preclinical. That is the single most important fact on this page, and most lists bury it under hype.
The split is worth seeing plainly. The GH-axis compounds have real human data showing they raise GH and IGF-1 and that the GH pulse is tied to deep sleep, but raising a hormone is not the same as demonstrating better sleep, and a dedicated sleep endpoint has not been run in large trials. DSIP, despite its name, rests on small, dated, largely Russian/preclinical studies with mixed results. Selank has small human anxiolytic data, not sleep-specific. Epitalon is essentially preclinical for sleep. The honest read is that usage here far outruns evidence, so the grade chart below is deliberately sobering.
A few anchored facts ground the grading. GHRH analogs and GH secretagogues do reliably increase GH and IGF-1 in humans (Sexual Medicine Reviews / NIH, Sigalos & Pastuszak, 2018, retrieved 2026-06-19). MK-677 raised GH and IGF-1 over 12 months in older adults and is repeatedly reported by users to deepen sleep, though without a controlled sleep endpoint (Annals of Internal Medicine / NIH, Nass et al., 2008, retrieved 2026-06-19). DSIP's sleep effects remain unconfirmed in modern controlled trials, with most data old and inconsistent (review, NIH/PubMed, retrieved 2026-06-19). Read these as "the mechanism is plausible," not "better sleep is proven."
Can your wearable tell you if a sleep peptide is working?
A sleep tracker gives you a cheap, objective feedback layer most peptide users skip — but the tracker is a proof tool here, not the subject, and the measurement methodology deserves its own page. Used well, a multi-week deep-sleep, REM, and latency trend can flag whether a peptide is helping, doing nothing, or just adding vivid dreams.
Here is the practical, info-gain framing. Because no sleep peptide has a clean large human trial, your own data is the most honest readout you have. Track deep sleep, REM, sleep latency, and how you feel for two to four weeks before starting anything, then watch the trend after. Our own community tracking suggests the realistic change on a GH-axis run is modest, on the order of a handful of extra deep-sleep minutes and a slightly shorter latency, sitting inside a wide night-to-night noise band, not a dramatic transformation. That is exactly why a single good night proves nothing and a multi-week trend proves something. We keep the full tracking methodology, what counts as a meaningful change, and how to control for noise on its own page, see how to track sleep changes on peptides; and for when in the night to dose to bias toward deep sleep, see timing GH peptides for deep sleep. The point here is narrow: measure before you trust the hype.
Our take: The most useful thing a sleep-peptide user can do is also the cheapest, establish a personal deep-sleep and latency baseline first, then let your own multi-week trend, not a forum, decide whether the peptide earns its place. If your tracker says nothing changed after a month, believe the tracker.
Each candidate, briefly (with where to go deeper)
Here is each candidate in two-to-four sentences — enough to place it, with a link up to its full guide for the science. This page owns the "which one, and why" decision; the mechanism, dosing, and side-effect depth live on each compound's hub.
Ipamorelin + CJC-1295
The community's default GH-axis sleep stack: a clean, selective GH-releasing peptide paired with a long-acting GHRH analog, aimed at a stronger overnight GH pulse and deeper slow-wave sleep. There is human data that the combination raises GH and IGF-1, but no controlled sleep trial, and it deepens sleep rather than sedating. Full guides: ipamorelin complete guide and CJC-1295 complete guide.
DSIP
Delta sleep-inducing peptide, the one peptide built for sleep, used to target sleep onset and quality directly rather than through the GH axis. Its reputation outruns its evidence: the human work is old, small, and largely Russian/preclinical, with mixed results, so treat it as an experiment, not a sure thing. Full guide: DSIP complete guide.
MK-677 (Ibutamoren)
An oral GH secretagogue (not technically a peptide) and the needle-free way to nudge the same axis, widely reported to deepen sleep and intensify dreams. It has the most human GH/IGF-1 data of the group but no controlled sleep endpoint, and water retention, morning grogginess, and reduced insulin sensitivity are common. Full guide: MK-677 complete guide.
Selank
An anxiolytic peptide derived from a natural immunopeptide, used for sleep when a racing, anxious mind is the real blocker at lights-out. It calms rather than sedates, so it helps onset indirectly; its human data is small and anxiety-focused, not sleep-specific. People who want its daytime-focus sister peptide often pair it with Semax. Full guide: selank complete guide.
Sermorelin
The milder, older GHRH analog, FDA-approved as a diagnostic agent for GH deficiency, not for sleep. People who track it for sleep want the gentlest GH-axis nudge with the longest clinical history, accepting a weaker GH rise than CJC-1295. Full guide: sermorelin complete guide.
Epitalon
A short pineal-pathway peptide tied to melatonin and circadian rhythm rather than to a single night's depth, tried mostly for age-related decline and rhythm disruption. The data behind it is preclinical and old, much of it from longevity research, so its sleep case is the thinnest of the group. Full guide: epitalon complete guide.
Tesamorelin (off-core)
A potent GHRH analog approved for HIV-associated lipodystrophy, occasionally used off-label for its strong GH/IGF-1 effect, which can deepen sleep as a side effect. It is more a body-composition tool than a sleep-specific one, which is why sleep usage is low. Full guide: tesamorelin complete guide.
Do you even need a peptide to sleep better?
For most people the honest answer is no — consistent timing, light exposure, caffeine and alcohol timing, and a dark cool room drive the overwhelming majority of sleep quality, and a peptide is the wrong first move if those are not already in place. This is the trust gate most "best peptides" lists skip, and it is the highest-value advice on the page.
The reasoning is simple and uncomfortable. The GH-axis leaders work by amplifying overnight deep sleep, but if you are drinking coffee at 4 p.m., scrolling in bed, and going to sleep at a different time every night, there is little for a peptide to amplify, and you will likely credit the compound for gains better basics would have produced anyway. Run the foundation first: a fixed wake time, morning daylight, no caffeine after early afternoon, alcohol kept away from bedtime, and a cool dark room, then re-measure your deep sleep and latency. If sleep is still poor after the basics are genuinely dialed in, that is the point where the peptide question becomes reasonable, ideally with a clinician and your own tracker trend, not a forum, guiding it. And if you suspect a real sleep disorder like apnea, no peptide is the answer, you need a clinician and a sleep study.
Our take: A peptide cannot out-run bad sleep hygiene or an undiagnosed sleep disorder. The cheapest, most evidence-backed "sleep stack" is boring, fixed timing, morning light, no late caffeine, and it has to come first. Treat any peptide as a possible last few percent, never the foundation.
Who should be cautious, and who should not use these
Sleep peptides are not for everyone, and because they are research-grade and largely untested for this use, the responsible default is clinician oversight, not a self-directed cycle. The GH-axis compounds carry specific cautions, and the research-only supply chain adds quality risk on top.
A few hard lines worth stating. GH-axis stimulation raises IGF-1, so anyone with active cancer or a significant cancer history should avoid these without specialist guidance, since IGF-1 signaling is implicated in cell proliferation. People with diabetes or insulin resistance need caution with MK-677, which can worsen insulin sensitivity and cause fluid retention. None of these is used in pregnancy or breastfeeding. None of them treats sleep apnea, restless legs, or any diagnosed sleep disorder, and using them to self-treat one can delay real care. And because every option here is sold "for research use only," research-grade vials carry real risk of mislabeled potency, impurities, and non-sterility that no usage statistic captures. Before sourcing anything, see how to vet peptide quality and are peptides legal. None of this page is a substitute for a conversation with a qualified clinician.
Frequently Asked Questions
The bottom line
If you came here for a single "best peptide for sleep," the honest answer is layered. The community splits between two leaders: the Ipamorelin + CJC-1295 GH-axis stack, which deepens slow-wave sleep, and DSIP, the one peptide built for sleep, with oral MK-677 close behind. They work through different mechanisms, which is exactly why the right pick depends on your specific problem, latency, fragmentation, an anxious mind, or age-related decline, not on which compound has the loudest forum following.
The most valuable move is the one most lists skip: match the peptide to your sleep problem, get the foundation first, and measure. No sleep peptide has a large controlled human trial behind it, so usage here outruns evidence, and what tracking shows is a modest, noisy change, not a transformation. This page owns the "which peptide" decision; how to measure sleep changes and when to dose for deep sleep belong to their own pages linked above. Before any compound, dial in timing, light, and caffeine, rule out a real sleep disorder with a clinician, then let your own tracker trend decide whether a peptide earns its place. The final call belongs with a clinician who knows your health history. From here, the natural next reads are the guide to tracking sleep changes on peptides, the timing GH peptides for deep sleep, and how to vet peptide quality.
Sources
- Van Cauter E, Plat L, Copinschi G. "Interrelations between sleep and the somatotropic axis." Sleep / Endocrine Reviews, 1998. NIH/PubMed 9626554. Retrieved 2026-06-19. https://pubmed.ncbi.nlm.nih.gov/9626554/
- Sigalos JT, Pastuszak AW. "The Safety and Efficacy of Growth Hormone Secretagogues." Sexual Medicine Reviews / NIH, 2018. NIH/PubMed 29070178. Retrieved 2026-06-19. https://pubmed.ncbi.nlm.nih.gov/29070178/
- Nass R, Pezzoli SS, Oliveri MC, et al. "Effects of an Oral Ghrelin Mimetic (MK-677) on Body Composition and Clinical Outcomes in Healthy Older Adults." Annals of Internal Medicine, 2008. NIH/PubMed 19017583. Retrieved 2026-06-19. https://pubmed.ncbi.nlm.nih.gov/19017583/
- Review of delta sleep-inducing peptide (DSIP) and its sleep effects. NIH/PubMed, historical review. NIH/PubMed 6093424. Retrieved 2026-06-19. https://pubmed.ncbi.nlm.nih.gov/6093424/
- U.S. Food & Drug Administration. Sermorelin (GH-deficiency diagnostic) and tesamorelin (Egrifta, HIV-associated lipodystrophy) labeling references. Retrieved 2026-06-19. https://www.accessdata.fda.gov/scripts/cder/daf/
- ProtocolPlus. "Community goal-usage data: sleep" (goals/sleep.json). First-party app data, 2026. n ≈ 2,600 users pursuing better sleep. Usage signal, not a clinical efficacy ranking.